A Double-blind, Placebo-controlled, Randomized, Single and Multiple Ascending Dose Study to Investigate the Safety and Pharmacokinetics of JNJ-39758979 in Healthy Japanese and Caucasian Adult Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 05 Sep 2013
At a glance
- Drugs JNJ 39758979 (Primary)
- Indications Asthma
- Focus Adverse reactions; Pharmacokinetics
- 30 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Dec 2010 Actual initiation date changed from Feb 2010 to Mar 2010 as reported by ClinicalTrials.gov.
- 10 Dec 2010 Planned End Date changed from 1 Nov 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov.